Duration of dual antiplatelet therapy after drug-eluting stent implantation: will we ever reach a consensus?
- 11 March 2015
- journal article
- research article
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 36 (20), 1219-1222
- https://doi.org/10.1093/eurheartj/ehv053
Abstract
No abstract availableThis publication has 24 references indexed in Scilit:
- Optimal Duration of Dual Antiplatelet Therapy After Drug-Eluting Stent ImplantationCirculation, 2014
- The EXAMINATION Trial (Everolimus-Eluting Stents Versus Bare-Metal Stents in ST-Segment Elevation Myocardial Infarction)JACC: Cardiovascular Interventions, 2013
- A New Strategy for Discontinuation of Dual Antiplatelet TherapyJournal of the American College of Cardiology, 2012
- Effect of Biolimus-Eluting Stents With Biodegradable Polymer vs Bare-Metal Stents on Cardiovascular Events Among Patients With Acute Myocardial InfarctionJAMA, 2012
- Short- and Long-Term Outcomes With Drug-Eluting and Bare-Metal Coronary StentsCirculation, 2012
- Short- Versus Long-Term Duration of Dual-Antiplatelet Therapy After Coronary StentingCirculation, 2012
- Comparison of drug-eluting stents with bare metal stents in patients with ST-segment elevation myocardial infarctionEuropean Heart Journal, 2012
- Drug-Eluting Stent Thrombosis: Increasingly Recognized But Too Frequently OveremphasizedJournal of the American College of Cardiology, 2006
- A Clinical Trial Comparing Three Antithrombotic-Drug Regimens after Coronary-Artery StentingNew England Journal of Medicine, 1998
- A Randomized Comparison of Antiplatelet and Anticoagulant Therapy after the Placement of Coronary-Artery StentsNew England Journal of Medicine, 1996